{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:51:58Z","timestamp":1775764318048,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0022\/2018\/A1"],"award-info":[{"award-number":["0022\/2018\/A1"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00912","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T05:03:07Z","timestamp":1568091787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Yu","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Qing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Wing Fai","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Lai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty Yuen Kwan","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Kam Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ygeno.2012.11.009","article-title":"Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line","volume":"101","author":"AbuHammad","year":"2013","journal-title":"Genomics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-4598-5-29","article-title":"Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues","volume":"5","author":"Bandr\u00e9s","year":"2006","journal-title":"Mol. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","article-title":"The Warburg effect and drug resistance","volume":"173","author":"Bhattacharya","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00280-006-0291-9","article-title":"Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia","volume":"59","author":"Cao","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2013.07.035","article-title":"Is cancer a metabolic disease","volume":"184","author":"Coller","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drup.2012.01.006","article-title":"The tumor microenvironment is a dominant force in multidrug resistance","volume":"15","author":"Correia","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3399","article-title":"DNA repair dysregulation from cancer driver to therapeutic target","volume":"12","author":"Curtin","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2005.02.020","article-title":"Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma","volume":"43","author":"Fautrel","year":"2005","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.15419\/bmrat.v4i10.372","article-title":"Colorectal cancer in the world: incidence, mortality and risk factors","volume":"4","author":"Gandomani","year":"2017","journal-title":"Biomed. Res. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/carcin\/bgh283","article-title":"Apoptosis in the development and treatment of cancer","volume":"26","author":"Gerl","year":"2005","journal-title":"Carcinogenesis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"key":"B15","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B16","first-page":"509","article-title":"Metabolic Activation of N-Hydroxy-2-aminofluorene and N-Hydroxy-2-acetylaminofluorene by Monomorphic N-Acetyltransferase (NAT1) and Polymorphic N-Acetyltransferase (NAT2) in Colon Cytosols of Syrian Hamsters Congenic at the NAT2 Locus","volume":"53","author":"Hein","year":"1993","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1046\/j.1523-1747.2002.01786.x","article-title":"Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency","volume":"118","author":"Helmbach","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B20","first-page":"2422","article-title":"Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas","volume":"56","author":"Krajewska","year":"1996","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep05510","article-title":"Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells","volume":"4","author":"Law","year":"2014","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.18632\/oncotarget.6980","article-title":"Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers","volume":"7","author":"Law","year":"2016","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fphar.2017.00388","article-title":"N-desmethyldauricine induces autophagic cell death in apoptosis-defective cells via Ca2+ mobilization","volume":"8","author":"Law","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1002\/cncr.25426","article-title":"Dasatinib induces autophagic cell death in human ovarian cancer","volume":"116","author":"Le","year":"2010","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1021\/acs.analchem.8b04281","article-title":"Method for Quantification of Ribonucleotides and Deoxyribonucleotides in Human Cells Using (Trimethylsilyl)diazomethane Derivatization Followed by Liquid Chromatography\u2013Tandem Mass Spectrometry","volume":"91","author":"Li","year":"2018","journal-title":"Anal. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.12659\/MSM.909186","article-title":"Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway","volume":"24","author":"Liu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-3-319-48683-3_3","article-title":"Molecular mechanism of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1073\/pnas.94.6.2345","article-title":"Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis","volume":"94","author":"McCurrach","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41598-017-00130-x","article-title":"Lack of XPC leads to a shift between respiratory complexes I and II but sensitizes cells to mitochondrial stress","volume":"7","author":"Mori","year":"2017","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-018-0413-4","article-title":"Pan-class I PI3-kinase inhibitor BKM120 induces MEK1\/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax\/Bak and p53","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Cell Death Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19135","DOI":"10.1073\/pnas.1014047107","article-title":"Uncoupling the Warburg effect from cancer","volume":"107","author":"Najafov","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1101\/gad.276725.115","article-title":"Inactivation of prosurvival Bcl-2 proteins activates Bax\/Bak through the outer mitochondrial membrane","volume":"30","author":"O\u2019neill","year":"2016","journal-title":"Genes Dev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3892\/or.6.2.365","article-title":"Prognostic significance of Bcl-2, Bcl-xL\/S, Bax and Bak expressions in colorectal carcinomas","volume":"6","author":"Ogura","year":"1999","journal-title":"Oncol. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1158\/1535-7163.MCT-10-0274","article-title":"Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in GI tumor cells","volume":"9","author":"Park","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7497\/j.issn.2095-3941.2014.01.001","article-title":"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI40087","article-title":"XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas","volume":"121","author":"Rezvani","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbabio.2010.12.006","article-title":"XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species","volume":"1807","author":"Rezvani","year":"2011","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00003088-200544040-00002","article-title":"Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism","volume":"44","author":"Rochat","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.dnarep.2013.08.013","article-title":"Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA","volume":"12","author":"Shell","year":"2013","journal-title":"DNA Repair (Amst.)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/20959","article-title":"Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC","volume":"399","author":"Shimizu","year":"1999","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1097-2765(00)80132-X","article-title":"Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair","volume":"2","author":"Sugasawa","year":"1998","journal-title":"Mol. Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1038\/cddis.2013.18","article-title":"Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells","volume":"4","author":"Tai","year":"2013","journal-title":"Cell Death Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jnci\/92.1.18","article-title":"Epigenetic determinants of resistance to etoposide regulation of Bcl- x(L) and Bax by tumor microenvironmental factors","volume":"92","author":"Taylor","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/jnci\/djj395","article-title":"Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak","volume":"98","author":"Tomiyama","year":"2006","journal-title":"J. Natl. Cancer Inst"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","article-title":"Drug resistance and new therapies in colorectal cancer","volume":"24","author":"Van Der Jeught","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4251\/wjgo.v7.i12.422","article-title":"Colorectal cancer diagnosis: pitfalls and opportunities","volume":"7","author":"Vega","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj\/onc\/1205010","article-title":"The apoptosis promoting Bcl-2 homologues Bak and Nbk\/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines","volume":"21","author":"von Haefen","year":"2002","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jcb.22126","article-title":"Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation","volume":"107","author":"Wong","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"B52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","article-title":"Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia","volume":"65","author":"Xu","year":"2005","journal-title":"Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00912\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:22:18Z","timestamp":1664324538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00912\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":52,"alternative-id":["10.3389\/fphar.2019.00912"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00912","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"article-number":"912"}}